IFN-α is currently used for the treatment for chronic HCV infection, HBV infection, and many malignant tumors, including hepatitis B, melanoma, hairy cell leukemia, and non-Hodgkin's lymphoma. Here, IFNA1 is linked to non-Hodgkin lymphoma.